Organometallics
Article
NMR (benzene-d6): δ −2.7 (4B), −7.5 (4B), −15.2 (2B). IR (KBr,
cm−1): ν 2559 (BH). Anal. Calcd for C24H56B10N4Ti (2h): C, 51.78; H,
10.14; N, 10.06. Found: C, 52.24; H, 10.34; N, 10.06.
3H, CH3), 1.09 (m, 4H, CH2), 0.96 (m, 6H, CH2). 13C{1H} NMR
(pyridine-d5): δ 181.8, 180.0, 178.9 (NCN), 129.4, 129.3, 128.8, 128.5,
128.3, 126.5, 126.2, 125.9, 125.7, 122.9, 122.7, (phenyl C), 99.8, 80.7
(cage C), 59.1, 58.0, 57.3, (NCH), 46.3, 44.6, 36.7, 35.0, 34.8, 34.7, 34.4,
25.9, 25.3, 25.1, 24.9, 24.8, 24.3, 22.6, 21.6 (CH2 and CH3). 11B{1H}
NMR (pyridine-d5): δ −2.1 (3B), −6.7 (7B). IR (KBr, cm−1): ν 2582
(BH). Anal. Calcd for C49H82B10N6O0.5Zr (6b + 0.5 THF): C, 61.14; H,
8.59; N, 8.73. Found: C, 61.28; H, 8.92; N, 8.38.
Preparation of [η2-iPrNC(Bun)NPri]2Hf(η2-C2B10H10) (2i). This
complex was prepared as colorless crystals from Li2C2B10H10 [prepared
in situ from o-C2B10H12 (0.72 g, 5.00 mmol) and nBuLi (6.3 mL, 10.00
mmol, 1.6 M in hexane)] and [η2-iPrNC(Bun)NPri]2HfCl2 (3.08 g, 5.00
mmol) in toluene (40 mL) using the same procedure reported for 2c:
yield 2.85 g (83%). 1H NMR (benzene-d6): 3.67 (m, 4H, NCH), 2.05 (t,
J = 7.8 Hz, 4H, CH2), 1.34 (m, 4H, CH2), 1.20 (d, J = 6.3 Hz, 12H, CH3),
1.16 (d, J = 6.3 Hz, 12H, CH3), 1.11 (m, 4H, CH2), 0.78 (t, J = 7.2 Hz,
6H, CH3). 13C{1H} NMR (benzene-d6): δ 181.4 (NCN), 116.0 (cage
C), 48.5 (NCH), 29.1, 26.6, 25.1, 24.8, 23.3, 13.6 (CH2 and CH3).
11B{1H} NMR (benzene-d6): δ −0.8 (2B), −0.7 (2B), −7.5 (4B), −15.2
Preparation of [η2-iPrNC(nBu)NPri]2Hf[σ:σ:σ-{[iPrNC(NPri)-
C2B10H10}] (6i). This complex was prepared as a colorless solid from
2i (206 mg, 0.3 mmol) and N,N′-diisopropylcarbodiimide (76 mg, 0.6
mmol) in toluene (20 mL) using the same procedure reported for 3b:
yield 223 mg (91%). 1H NMR (benzene-d6): δ 4.91 (m, 1H), 4.39 (m,
1H), 4.22 (m, 1H) 3.69 (m, 2H), 3.54 (m, 1H) (NCH), 2.09 (m, 4H,
CH2), 1.83 (d, J = 8.4 Hz, 3H, CH3), 1.58 (d, J = 8.4 Hz, 6H, CH3), 1.40
(d, J = 8.4 Hz, 3H, CH3), 1.35 (d, J = 8.4 Hz, 3H, CH3), 1.31 (m, 8H,
CH2), 1.25 (m, 9H) (CH3), 1.17 (d, J = 8.4 Hz, 3H, CH3), 1.06 (d, J =
8.4 Hz, 3H, CH3), 0.90 (d, J = 8.4 Hz, 3H, CH3), 0.86 (d, J = 8.4 Hz, 3H,
CH3), 0.83 (m, 6H, CH3). 13C{1H} NMR (benzene-d6): δ 183.8, 181.6,
151.6 (NCN), 106.7, 81.6 (cage C), 49.0, 48.2, 47.7, 47.3, 46.7 (NCH),
29.2, 29.0, 28.7, 27.2, 27.1, 25.9, 25.4, 25.3, 25.0, 24.7, 24.6, 24.3, 23.6,
23.5, 23.4, 21.9, 13.6 (CH2 and CH3). 11B{1H} NMR (benzene-d6): δ
−2.09 (3B), −7.0 (3B), −10.0 (3B), −11.5 (1B). IR (KBr, cm−1): ν
2580, 2550 (BH). Anal. Calcd for C31H70B10HfN6 (6i): C, 45.77; H,
8.67; N, 10.33. Found: C, 45.77; H, 8.57; N, 10.16.
(2B). IR (KBr, cm−1): ν 2559 (BH). Anal. Calcd for C24H56B10N4Hf
(2i): C, 41.94; H, 8.21; N, 8.15. Found: C, 41.87; H, 8.30; N, 7.98.
Preparation of [η2-CyNC(Ph)NCy]2Zr[σ:σ:σ-{(Ph)2C(O)C2B10H10}]
(3b). To a stirring suspension of 2b (174 mg, 0.2 mmol) in toluene
(10 mL) at room temperature was added benzophenone (36 mg, 0.2
mmol), and the mixture was stirred at room temperature for 48 h. A clear
colorless solution was formed. After concentration of the solution to ca.
3 mL, the resulting solution stood at room temperature overnight to
yield 3b as colorless crystals (200 mg, 95%). 1H NMR (pyridine-d5): δ
8.31 (m, 4H), 7.65 (m, 6H), 7.55 (m, 2H), 7.49 (m, 4H), 7.42 (m, 2H),
7.31 (m, 2H) (phenyl H), 2.13 (m, 3H), 1.97 (m, 6H), 1.85 (m, 3H),
1.61 (m, 12H), 1.38 (m, 4H), 1.15 (m, 6H), 1.05 (m, 6H), 0.96 (m, 4H)
(Cy). 13C{1H} NMR (pyridine-d5): δ 182.5 (NCN), 129.3, 128.7, 128.3,
128.0, 127.2, 126.9, 126.8, 126.6, 125.9, 125.1, 122.3 (phenyl C), 107.7,
100.3 (cage C), 91.6 (C-O), 57.8 (NCH), 34.9, 25.1, 25.0, 24.8 (CH2).
11B{1H} NMR (pyridine-d5): δ −2.1 (4B), −7.5 (6B). IR (KBr, cm−1): ν
Preparation of [η2-CyNC(Me)NCy]2Zr[σ:σ:σ-{[PhN(CO)C2B10H10}]
(7a). This complex was prepared as colorless crystals from 2a (135
mg, 0.2 mmol) and PhNCO (24 mg, 0.2 mmol) in toluene (10 mL)
1
using the same procedure reported for 3b: yield 148 mg (93%). H
NMR (pyridine-d5): δ 7.43 (m, 2H), 7.33 (m, 2H), 7.25 (m, 1H)
(phenyl H), 4.10 (m, 2H, NCH), 3.59 (m, 2H, THF), 2.91 (m, 2H,
NCH), 2.30 (s, 3H), 2.27 (s, 3H) (CH3), 1.99 (m, 2H), 1.76 (m, 18H),
1.59 (m, 4H), 1.43 (m, 2H), 1.27 (m, 14H), 0.92 (m, 2H) (CH2+THF).
13C{1H} NMR (pyridine-d5): δ 183.5, 180.6, 171.8 (NCN and CO),
143.7, 128.0, 127.4, 125.7 (phenyl C), 88.6, 81.6 (cage C), 57.9, 56.0
(NCH), 35.5, 34.0, 32.8, 31.0, 25.7, 24.9, 15.1, 13.5 (CH2 and CH3).
11B{1H} NMR (pyridine-d5): δ −2.7 (4B), −6.9 (6B). IR (KBr, cm−1): ν
2563 (BH). Anal. Calcd for C61H90B10N4O3Zr (3b + 2THF): C, 64.79;
H, 7.59; N, 5.70. Found: C, 64.95; H, 7.12; N, 5.69.
Preparation of [η2-CyNC(Ph)NCy]2Zr[σ:σ:σ-{[-(CH2)5-]C(O)-
C2B10H10}] (4b). To a stirring suspension of 2b (174 mg, 0.20 mmol)
in toluene (10 mL) at room temperature was added cyclohexanone (20
mg, 0.20 mmol), and the mixture was stirred at room temperature for 48
h. A clear colorless solution was formed. After concentration of the
solution to ca. 3 mL, the resulting solution stood at room temperature
2596, 2564 (BH). Anal. Calcd for C37H65B10N5OZr (7a): C, 55.81; H,
8.23; N, 8.80. Found: C, 55.79; H, 8.29; N, 8.43.
1
overnight to yield 4b as colorless crystals (156 mg, 87%). H NMR
(pyridine-d5): δ 7.56 (m, 4H), 7.50 (m, 4H), 7.42 (m, 2H) (phenyl H),
3.36 (m, 2H, NCH), 2.99 (m, 2H, NCH), 2.42 (m, 2H, CH2), 1.99 (m,
4H, CH2), 1.72 (m, 24H, CH2), 1.46 (m, 6H, CH2), 1.06 (m, 14H,
CH2). 13C{1H} NMR (pyridine-d5): δ 181.2 (NCN), 132.1, 129.2,
128.3, 128.0, 127.4, 126.9, 125.9, 122.3 (phenyl C), 106.1, 100.7 (cage
C), 84.9 (C-O), 57.1 (NCH), 39.5, 34.9, 34.4, 25.3, 25.0, 22.6, 13.1
(CH2). 11B{1H} NMR (pyridine-d5): δ −5.5 (6B), −10.0 (4B). IR (KBr,
cm−1): ν 2570 (BH). Anal. Calcd for C46H74B10N4OZr (4b): C, 61.50;
H, 8.30; N, 6.24. Found: C, 61.38; H, 8.36; N, 6.03.
Preparation of [η2-CyNC(Ph)NCy]2Zr[σ:σ:σ-{[nBuNC(S)C2B10H10}]
(8b). This complex was prepared as yellow crystals from 2b (174 mg, 0.2
mmol) and nBuNCS (46 mg, 0.4 mmol) in toluene (10 mL) using the
same procedure reported for 3b. Recrystallization from a mixed solvent
of hexane and ether (1/2 in v/v) afforded 8b (144 mg, 79%). 1H NMR
(benzene-d6): δ 7.77 (d, J = 7.5 Hz, 1H), 7.30 (d, J = 7.5 Hz, 1H), 7.23
(m, 1H), 7.12 (m, 7H) (phenyl H), 4.83 (m, 1H), 4.24 (m, 1H), 4.01
(m, 1H), 3.30 (m, 1H) (NCH), 2.91 (m, 1H), 2.64 (m, 1H), 2.06 (m,
2H), 1.86 (m, 8H), 1.69 (m, 18H), 1.44 (m, 6H) (CH2), 1.04 (t, J = 7.2
Hz, 3H, CH3), 1.01 (m, 4H), 0.90 (m, 6H) (CH2). 13C{1H} NMR
(benzene-d6): δ 204.4, 186.1, 180.2 (NCN and CS), 133.0, 130.9, 130.2,
130.1, 129.8, 128.9, 126.5, 126.4, 126.3 (phenyl C), 95.4, 92.3 (cage C),
60.3, 59.1, 58.2, 58.1, 50.4 (NCH and NCH2), 44.3, 38.0, 36.9, 36.1,
35.8, 35.4, 35.3, 34.1, 33.8, 31.7, 31.5, 26.7, 26.5, 26.2, 25.8, 25.5, 25.3,
25.2, 21.4, 19.6, 14.5, 13.1 (CH2 and CH3). 11B{1H} NMR (benzene-
d6): δ −2.5 (4B), −6.8 (6B). IR (KBr, cm−1): ν 2563 (BH). Anal. Calcd
for C45H73B10N5SZr (8b): C, 59.04; H, 8.04; N, 7.65. Found: C, 59.07;
H, 7.98; N, 7.82.
Preparation of [η2-CyNC(Me)NCy]2Zr[σ:σ:σ-{[NC(Ph)C2B10H10}]
(5a). This complex was prepared as yellow crystals from 2a (270 mg, 0.4
mmol) and benzonitrile (51 mg, 0.5 mmol) in toluene (20 mL) using
1
the same procedure reported for 3b: yield 237 mg (76%). H NMR
(benzene-d6): δ 8.21 (m, 2H), 7.02 (m, 3H) (phenyl H), 3.31 (m, 4H,
NCH), 1.87 (m, 8H, CH2), 1.69 (s, 6H, CH3), 1.65 (m, 8H), 1.55 (m,
12H), 1.29 (m, 8H), 1.12 (m, 4H) (CH2). 13C{1H} NMR (benzene-d6):
δ 179.4 (NCN), 172.3 (CN), 135.4, 131.0, 129.8, 128.1 (phenyl C),
104.1, 99.2 (cage C), 56.9 (NCH), 35.1, 26.0, 13.8 (CH2). 11B{1H}
NMR (benzene-d6): δ −1.5 (3B), −5.0 (3B), −8.9 (4B). IR (KBr,
cm−1): ν 2585 (BH). Anal. Calcd for C37H65B10N5Zr (5): C, 57.03; H,
8.41; N, 8.99. Found: C, 56.91; H, 8.20; N, 9.01.
Preparation of [η2-iPrNC(Bun)NPri]2Hf[σ:σ:σ-{[nBuNC(S)-
C2B10H10}] (8i). This complex was prepared as a light yellow solid
from 2i (206 mg, 0.3 mmol) and nBuNCS (69 mg, 0.6 mmol) in toluene
(10 mL) using the same procedure reported for 3b: yield 209 mg (87%).
1H NMR (benzene-d6): δ 4.65 (m, 2H, NCH), 3.58 (m, 4H, NCH
+CH2), 2.10 (q, J = 7.2, 4H, CH2), 1.61 (m, 2H, CH), 1.41 (m, 6H), 1.18
(m, 19H), 0.98 (m, 6H), 0.87 (m, 12H) (CH2 and CH3). 13C{1H} NMR
(benzene-d6): δ 205.3, 187.8, 183.0 (NCN and CS), 102.7, 91.5 (cage
C), 51.0, 49.5, 48.2, 47.9, 47.6 (NCH and NCH2), 30.6, 29.7, 29.5, 28.2,
27.2, 26.8, 26.6, 25.1, 25.0, 24.5, 24.3, 24.0, 23.6, 23.4, 23.3, 21.2, 14.3,
13.6, 13.5 (CH2 and CH3). 11B{1H} NMR (benzene-d6): δ −3.3 (3B),
−7.0 (4B), −8.7 (2B), −12.8 (1B). IR (KBr, cm−1): ν 2594, 2564 (BH).
Preparation of [η2-CyNC(Ph)NCy]2Zr[σ:σ:σ-{[iPrNC(NiPr)-
C2B10H10}] (6b). This complex was prepared as colorless crystals from
2b (174 mg, 0.2 mmol) and N,N′-diisopropylcarbodiimide (25 mg, 0.2
mmol) in toluene (10 mL) using the same procedure reported for 3b:
yield 176 mg (95%). 1H NMR (pyridine-d5): δ 7.73 (m, 2H), 7.67 (m,
4H), 7.52 (m, 4H) (phenyl H), 4.82 (m, 2H, NCH), 3.77 (m, 2H,
THF), 3.35 (m, 2H, NCH), 2.99 (m, 2H, NCH), 2.45 (m, 2H, CH2),
2.15 (m, 2H, CH2), 2.05 (m, 8H, CH2), 1.95 (d, J = 6.0 Hz, 3H, CH3),
1.88 (d, J = 6.0 Hz, 3H, CH3), 1.79 (m, 12H, CH2), 1.63 (m, 2H, THF),
1.45 (m, 6H, CH2), 1.23 (d, J = 6.0 Hz, 3H, CH3), 1.20 (d, J = 6.0 Hz,
4298
dx.doi.org/10.1021/om400458r | Organometallics 2013, 32, 4292−4300